Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.
Clinical trial NCT07644403 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07644403
- Sponsor
- Suzhou Immunofoco Biotechnology Co., Ltd
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2027-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.